Conversion from cyclosporine to sirolimus in stable renal transplant recipients.

Abstract

BACKGROUND Conversion from cyclosporine (CsA) to sirolimus (SRL) has mainly been done in clinical conditions warranting calcineurin inhibitor discontinuation. Little is known about the clinical outcome of conversion in renal transplant recipients without transplant dysfunction. METHODS This prospective, open-label, multicentric pilot study evaluates the… (More)

Topics

  • Presentations referencing similar topics